GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AEterna Zentaris Inc (NAS:AEZS) » Definitions » Enterprise Value

AEterna Zentaris (AEterna Zentaris) Enterprise Value : $-24.32 Mil (As of Apr. 28, 2024)


View and export this data going back to 2000. Start your Free Trial

What is AEterna Zentaris Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, AEterna Zentaris's Enterprise Value is $-24.32 Mil. AEterna Zentaris's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-18.01 Mil. Therefore, AEterna Zentaris's EV-to-EBIT ratio for today is 1.35.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, AEterna Zentaris's Enterprise Value is $-24.32 Mil. AEterna Zentaris's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-17.84 Mil. Therefore, AEterna Zentaris's EV-to-EBITDA ratio for today is 1.36.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, AEterna Zentaris's Enterprise Value is $-24.32 Mil. AEterna Zentaris's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $4.50 Mil. Therefore, AEterna Zentaris's EV-to-Revenue ratio for today is -5.41.


AEterna Zentaris Enterprise Value Historical Data

The historical data trend for AEterna Zentaris's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AEterna Zentaris Enterprise Value Chart

AEterna Zentaris Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.26 2.58 -22.01 -34.99 -24.71

AEterna Zentaris Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -34.99 -33.63 -29.45 -26.40 -24.71

Competitive Comparison of AEterna Zentaris's Enterprise Value

For the Biotechnology subindustry, AEterna Zentaris's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AEterna Zentaris's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AEterna Zentaris's Enterprise Value distribution charts can be found below:

* The bar in red indicates where AEterna Zentaris's Enterprise Value falls into.



AEterna Zentaris Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

AEterna Zentaris's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

AEterna Zentaris's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AEterna Zentaris  (NAS:AEZS) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

AEterna Zentaris's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-24.316/-18.008
=1.35

AEterna Zentaris's current Enterprise Value is $-24.32 Mil.
AEterna Zentaris's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18.01 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

AEterna Zentaris's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=-24.316/-17.839
=1.36

AEterna Zentaris's current Enterprise Value is $-24.32 Mil.
AEterna Zentaris's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17.84 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

AEterna Zentaris's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-24.316/4.498
=-5.41

AEterna Zentaris's current Enterprise Value is $-24.32 Mil.
AEterna Zentaris's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AEterna Zentaris Enterprise Value Related Terms

Thank you for viewing the detailed overview of AEterna Zentaris's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


AEterna Zentaris (AEterna Zentaris) Business Description

Traded in Other Exchanges
Address
222 Bay Street, Suite 3000, PO Box 53, c/o Norton Rose Fulbright Canada, LLP, Toronto, ON, CAN, M5K 1E7
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland.